SkrivarhaugT, BangstadHJ, SteneLC, et al.: Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway. Diabetologia, 2006; 49:298–305.
2.
LieblA, HenrichsHR, HeinemannL, et al.: Continuous glucose monitoring: evidence and consensus statement for clinical use. J Diabetes Sci Technol, 2013; 7:500–519.
3.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group: Quality-of-life measures in children and adults with type 1 diabetes: Juvenile Diabetes Research Foundation Continuous Glucose Monitoring randomized trial. Diabetes Care, 2010; 33:2175–2177.
4.
BergenstalRM, KlonoffDC, GargSK, et al.: Threshold-based insulin-pump interruption for reduction of hypoglycemia. N Engl J Med, 2013; 369:224–232.
5.
ChoudharyP, OlsenBS, CongetI, et al.: Hypoglycemia prevention and user acceptance of an insulin pump system with predictive low glucose management. Diabetes Technol Ther, 2016; 18:288–291.
6.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group: Prolonged nocturnal hypoglycemia is common during 12 months of continuous glucose monitoring in children and adults with type 1 diabetes. Diabetes Care, 2010; 33:1004–1008.
7.
RuanY, ThabitH, LeelarathnaL, et al.: Variability of insulin requirements over 12 weeks of closed-loop insulin delivery in adults with type 1 diabetes. Diabetes Care, 2016; 39:830–832.
8.
BarnardK, JamesJ, KerrD, et al.: Impact of chronic sleep disturbance for people living with T1 diabetes. J Diabetes Sci Technol, 2016; 10:762–767.
